Accelerate Diagnostics Inc expected to post a loss of 14 cents a share - Earnings Preview

Accelerate Diagnostics

09/05/2023 13:11

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 11. 
    * The Denver Colorado-based  company is expected to report 
a
13.3% increase in revenue to $3.35 million from $2.96 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Accelerate
Diagnostics
Inc is for a loss of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $0.6​, below​ its last closing price
of $0.79. ​​​

This summary was machine generated May 9 at 12:11 GMT.  All
figures in US dollars  unless otherwise stated